Literature DB >> 10073407

Long-term complications and post-treatment follow-up of patients with Wilms' tumor.

R M Egeler1, J E Wolff, R A Anderson, M J Coppes.   

Abstract

An increasing number of children with Wilms' tumor can expect to be cured, reflecting the undisputed progress made in the treatment of children with this renal cancer. However, it does underscore the need to screen survivors for late effects of cancer therapy. Some of the late effects, such as those following radiation therapy, should be expected after a considerable latent period. Others, such as those occurring after the administration of certain chemotherapeutics agents, are commonly immediate, usually transient, but occasionally permanent. Although children seem to tolerate acute toxicities of therapy better than do adults, the growing child may be more vulnerable to the delayed adverse sequelae of cancer therapy, such as effects on growth, fertility, and neuropsychological function. This article reviews many of the late effects seen in survivors of Wilms' tumor and the way in which these effects relate to the different therapeutical modalities used (surgery, chemotherapy, and radiation).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073407

Source DB:  PubMed          Journal:  Semin Urol Oncol        ISSN: 1081-0943


  7 in total

Review 1.  Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.

Authors:  Deborah P Jones; Sheri L Spunt; Daniel Green; James E Springate
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

2.  HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor.

Authors:  Seham M Ragab; Rehab M Samaka; Tahany M Shams
Journal:  Pathol Oncol Res       Date:  2009-07-17       Impact factor: 3.201

3.  S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor.

Authors:  Mei-Hong Li; Teresa Sanchez; Harold Yamase; Timothy Hla; Myat Lin Oo; Anna Pappalardo; Kevin R Lynch; Chen-Yong Lin; Fernando Ferrer
Journal:  Cancer Lett       Date:  2009-01-07       Impact factor: 8.679

4.  Characterization of a WiT49 cell line derived orthotopic model of Wilms tumor.

Authors:  Mei-Hong Li; Harold Yamase; Fernando Ferrer
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

5.  Dosimetric predictors of nephrotoxicity in patients receiving extended-field radiation therapy for gynecologic cancer.

Authors:  Hiroaki Kunogi; Nanae Yamaguchi; Yasuhisa Terao; Keisuke Sasai
Journal:  Radiat Oncol       Date:  2021-02-04       Impact factor: 3.481

Review 6.  Many faces of Wilms Tumor: Recent advances and future directions.

Authors:  Namita Bhutani; Pradeep Kajal; Urvashi Sharma
Journal:  Ann Med Surg (Lond)       Date:  2021-03-07

7.  Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment.

Authors:  Hiroaki Kunogi; Nanae Yamaguchi; Yasuhisa Terao; Keisuke Sasai
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.